Erypeg 75 Injection

Product Description

Product Details:

Effective Management of CKD-related Anemia

Erypeg 75 Injection is specially formulated to address anemia resulting from chronic kidney disease (CKD). By stimulating red blood cell production, it helps improve hemoglobin levels and alleviate the symptoms associated with anemia, such as fatigue and weakness. When administered as per a physician's guidance, it can contribute significantly to the betterment of anemic conditions in adults undergoing CKD treatment.


Precision Dosing with Pegylated Erythropoietin

Each vial of Erypeg 75 contains 75 mcg of pegylated human erythropoietin, ensuring precise and effective dosing. The pegylation enhances the durability of the medication in the body, allowing for sustained action and potentially less frequent administration as directed by a healthcare provider. Strict adherence to prescribed dosages optimizes treatment outcomes while maintaining safety.


Safe and Convenient Administration

Erypeg 75 Injection is designed for subcutaneous or intravenous administration, making it adaptable to healthcare facility protocols. The clear, colorless liquid is supplied as a single vial per box, simplifying inventory and use. To maximize therapeutic benefit and minimize risk, the injection should only be prepared and administered by medical professionals in accordance with established guidelines.